Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

High RiskFDA Device
Medical Devices

Becton Dickinson Infusion Therapy Systems Inc.: BD Cathena Safety IV Catheters Recalled for Needle Exposure Risk

Agency Publication Date: October 3, 2023
Share:
Sign in to monitor this recall

Summary

Becton Dickinson Infusion Therapy Systems Inc. is recalling approximately 98,000 BD Cathena Safety IV catheters with Multiguard Technology. These devices are being recalled because the needle safety shield may fail to engage, allowing the needle to pull through and leaving the contaminated point exposed. Consumers should be aware that this defect affects 20 GA 1.00 IN catheters from a specific production lot distributed across ten U.S. states.

Risk

A malfunction in the safety shield can leave a contaminated needle point exposed after use, posing a significant risk of accidental needlestick injuries and potential exposure to bloodborne pathogens.

What You Should Do

  1. Identify the affected product by checking the packaging for REF: 386862 and BD Cathena Safety IV catheter with BD Multiguard Technology (20 GA 1.00 IN, 1.1 x 25 mm).
  2. Verify the lot number on the individual package or case label; only Lot # 2238464 with UDI-DI (01)00382903868629 is included in this recall.
  3. Immediately stop using any catheters from the affected lot and set them aside for return or disposal according to your facility's safety protocols.
  4. Contact your healthcare provider or Becton Dickinson directly to report any issues or to receive instructions on returning the affected product and obtaining replacements.
  5. For further questions, contact the FDA at 1-888-463-6332 or visit www.fda.gov/medical-devices/medical-device-recalls.

Your Remedy Options

๐Ÿ“‹Other Action

Manufacturer and Healthcare Coordination

How to: Contact your healthcare provider or the manufacturer for further instructions and potential refund

Affected Products

Product: BD Cathena Safety IV catheter with BD Multiguard Technology, 20 GA 1.00 IN (1.1 x 25 mm 64 mL/min)
Model / REF:
REF: 386862
UPC Codes:
00382903868629
Lot Numbers:
2238464

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 92970
Status: Active
Manufacturer: Becton Dickinson Infusion Therapy Systems Inc.
Manufactured In: United States
Units Affected: 98,000 units
Distributed To: California, Florida, Georgia, Massachusetts, Minnesota, Missouri, Mississippi, New Jersey, Ohio, Texas

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.